Podcast - Quality by Design: Where We Stand Now

Feb 04, 2010
By BioPharm International Editors




Add this Podcast feed to your media player


Quality by Design: Where We Stand Now

On what aspects of Quality by Design is there now consensus within the industry and regulatory bodies, and what remains to be sorted out?

Join Laura Bush, Editor in Chief of BioPharm International and John Towns, Senior Director of Global CMC Regulatory Affairs at Eli Lilly, as they discuss the current state of QbD.



Click here to go to the main podcast page >>>

Related Links:
Quality by Design for Biotechnology Products—Part 1: A PhRMA Working Group's advice on applying QbD to biotech.

Convincing the Skeptics

Quality by Design A-MAb Case Study Challenges Conventional Thinking